Programs & Standards
The quality and safety of plasma protein therapeutics is the industry's foremost concern. In addition to rigorous government regulation, the industry has established additional, voluntary standards to ensure a safe supply of plasma and the therapies manufactured from it. A comprehensive, rigorous initiative to strengthen the continued safety and quality of life-saving plasma protein therapies worldwide, the Quality Standards of Excellence, Assurance and Leadership (QSEAL) certification represents steadfast industry commitment to producing safe plasma-derived therapies worldwide.
International Quality Plasma Program (IQPP) certification demonstrates that a plasma collection center is willing to exceed what is required by government regulation by providing a high-quality business operation and advance the safety and quality of committed donors and donated plasma.
These voluntary standards, as well as the industry-driven Patient Notification System and first-of-its-kind National Donor Deferral Registry, combine to deliver an added layer of safety to donated plasma and plasma protein therapies that treat patients worldwide.